Journal Home
Search for

Volume 66, Issue 10, Pages 958-963 (15 November 2009)


View previous. 15 of 24 View next.

Phthalates Exposure and Attention-Deficit/Hyperactivity Disorder in School-Age Children

Bung-Nyun Kima, Soo-Churl Choa, Yeni Kima, Min-Sup Shina, Hee-Jeong Yoob, Jae-Won Kima, Young Hee Yanga, Hyo-Won Kima, Soo-Young Bhangd, Yun-Chul HongcCorresponding Author Informationemail address

Received 23 February 2009; received in revised form 16 July 2009; accepted 22 July 2009. published online 14 September 2009.

Background

Very few studies have examined the association between attention-deficit/hyperactivity disorder (ADHD) and phthalate exposure in humans. The aim of this study was to investigate the impact of phthalates on symptoms of ADHD in school-age children.

Methods

A cross-sectional examination of urine phthalate concentrations was performed, and scores on measures of ADHD symptoms and neuropsychological dysfunction with regard to attention and impulsivity were obtained from 261 Korean children, age 8–11 years.

Results

Mono-2-ethylheyl phthalate (MEHP) and mono-2-ethyl-5-oxohexylphthalate (MEOP) for metabolites of Di-2-ethylhexylphthalate (DEHP) and mono-n-butyl phthalate (MNBP) for metabolites of dibutyl phthalate (DBP) were measured in urine samples. The mean concentrations of MEHP, MEOP, and MNBP were 34.0 μg/dL (SD = 36.3; range: 2.1–386.7), 23.4 μg/dL (SD = 23.0; range: .75–244.8), and 46.7 μg/L (SD = 21.4; range: 13.2–159.3), respectively. After adjustment for covariates, teacher-rated ADHD scores were significantly associated with DEHP metabolites but not with DBP metabolites. We also found significant relationships between the urine concentrations of metabolites for DBP and the number of omission and commission errors in continuous performance tests (CPT) after adjustment for covariates.

Conclusion

The present study showed a strong positive association between phthalate metabolites in urine and symptoms of ADHD among school-age children.

a Division of Child & Adolescent Psychiatry, Department of Psychiatry and Institute of Human Behavioral Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea

b Department of Psychiatry, Seoul National University Bundang Hospital, Seong-nam, Republic of Korea

c Department of Preventive Medicine, Seoul National University College of Medicine and Institute of Environmental Medicine, SNUMRC, Seoul, Republic of Korea

d Department of Psychiatry, Ulsan University Hospital, Ulsan, Republic of Korea

Corresponding Author InformationAddress correspondence to Yun-Chul Hong, M.D., Ph.D., Department of Preventive Medicine, Seoul National University College of Medicine and Institute of Environmental Medicine, SNUMRC, 28 Yongon-dong, Chongno-gu, Seoul 110-744, Republic of Korea

PII: S0006-3223(09)00952-4

doi:10.1016/j.biopsych.2009.07.034


View previous. 15 of 24 View next.